1. Home
  2. ENSC vs RAYA Comparison

ENSC vs RAYA Comparison

Compare ENSC & RAYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENSC
  • RAYA
  • Stock Information
  • Founded
  • ENSC 2003
  • RAYA 2019
  • Country
  • ENSC United States
  • RAYA China
  • Employees
  • ENSC N/A
  • RAYA N/A
  • Industry
  • ENSC Biotechnology: Pharmaceutical Preparations
  • RAYA Metal Fabrications
  • Sector
  • ENSC Health Care
  • RAYA Consumer Discretionary
  • Exchange
  • ENSC Nasdaq
  • RAYA Nasdaq
  • Market Cap
  • ENSC 6.4M
  • RAYA 6.1M
  • IPO Year
  • ENSC N/A
  • RAYA 2022
  • Fundamental
  • Price
  • ENSC $2.27
  • RAYA $5.88
  • Analyst Decision
  • ENSC
  • RAYA
  • Analyst Count
  • ENSC 0
  • RAYA 0
  • Target Price
  • ENSC N/A
  • RAYA N/A
  • AVG Volume (30 Days)
  • ENSC 149.6K
  • RAYA 378.3K
  • Earning Date
  • ENSC 11-11-2025
  • RAYA 01-01-0001
  • Dividend Yield
  • ENSC N/A
  • RAYA N/A
  • EPS Growth
  • ENSC N/A
  • RAYA N/A
  • EPS
  • ENSC N/A
  • RAYA N/A
  • Revenue
  • ENSC $7,413,722.00
  • RAYA $30,300,360.00
  • Revenue This Year
  • ENSC N/A
  • RAYA $20.95
  • Revenue Next Year
  • ENSC $1,354.55
  • RAYA N/A
  • P/E Ratio
  • ENSC N/A
  • RAYA N/A
  • Revenue Growth
  • ENSC 415.58
  • RAYA 49.10
  • 52 Week Low
  • ENSC $1.62
  • RAYA $3.65
  • 52 Week High
  • ENSC $14.67
  • RAYA $737.00
  • Technical
  • Relative Strength Index (RSI)
  • ENSC 51.69
  • RAYA 67.38
  • Support Level
  • ENSC $2.35
  • RAYA $5.04
  • Resistance Level
  • ENSC $2.63
  • RAYA $6.03
  • Average True Range (ATR)
  • ENSC 0.19
  • RAYA 0.81
  • MACD
  • ENSC 0.01
  • RAYA 0.38
  • Stochastic Oscillator
  • ENSC 34.60
  • RAYA 58.58

About ENSC Ensysce Biosciences Inc.

Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.

About RAYA Erayak Power Solution Group Inc.

Erayak Power Solution Group Inc engages in manufacturing, research and development, and wholesale and retail of power solution products. Its product portfolio includes sine wave and off-grid inverters, inverter and gasoline generators, battery, and smart chargers, and custom-designed products. It derives the majority revenue from four products namely inverters, chargers, power bank, and gasoline generators. The company generates the majority of its revenue from Inverters. The company geographically operates in China, Australia, Poland, U.K., and Germany. It derives maximum revenue from China.

Share on Social Networks: